Stryker Corporation (SYK) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extrem...
Stryker Corporation (SYK) currently trades at a P/E ratio of 37.42 (historical range: 32.73–53.44, median: 43.00), placing it at the 10th percentile — cheap relative to its history, P/S ratio of 4.94 (range: 4.32–7.02, 10th percentile — cheap relative to its history), EV/EBITDA of 145.96 (range: 28.19–199.38, 77th percentile).
Stryker Corporation appears undervalued relative to its historical range, with most valuation metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 37.42 | 32.73 | 43.00 | 53.44 | 10th | cheap relative to its history |
| P/S Ratio | 4.94 | 4.32 | 6.11 | 7.02 | 10th | cheap relative to its history |
| EV/EBITDA | 145.96 | 28.19 | 73.42 | 199.38 | 77th | above its historical average |
| FCF Yield | 0.00 | 0.00 | 0.01 | 0.03 | 23th | above its historical average |